uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 24, 2011

Recall of Counterfeit Extenze Tablets Containing Drugs

On February 23, 2011, the FDA announced that Biotab Nutraceuticals, Inc. was notified that two lots of counterfeit product purporting to be Extenze contain undeclared drug ingredients. Specifically, lot 0709241 contains tadalafil and sildenafil, and lot 0509075 contains tadalafil and sibutramine.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at